A detailed history of Fiduciary Family Office, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fiduciary Family Office, LLC holds 14,509 shares of NVO stock, worth $1.23 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
14,509
Previous 15,128 4.09%
Holding current value
$1.23 Million
Previous $2.16 Billion 20.0%
% of portfolio
0.57%
Previous 0.85%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$119.07 - $145.42 $73,704 - $90,014
-619 Reduced 4.09%
14,509 $1.73 Billion
Q2 2024

Aug 01, 2024

SELL
$122.71 - $146.91 $127,004 - $152,051
-1,035 Reduced 6.4%
15,128 $2.16 Billion
Q1 2024

May 07, 2024

SELL
$102.11 - $135.92 $143,260 - $190,695
-1,403 Reduced 7.99%
16,163 $2.08 Billion
Q4 2023

May 07, 2024

BUY
$87.78 - $105.45 $1.54 Million - $1.85 Million
17,566 New
17,566 $1.82 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fiduciary Family Office, LLC Portfolio

Follow Fiduciary Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Family Office, LLC with notifications on news.